| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.14 | 0.009 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.094 | 0.009 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.01 |